Study shows how collective behavior of bacterial colonies may contribute to antibiotic resistance

NewsGuard 100/100 Score

The bacterial equivalent of a traffic jam causes multilayered biofilms to form in the presence of antibiotics, shows a study published today in eLife.

The study reveals how the collective behavior of bacterial colonies may contribute to the emergence of antibiotic resistance. These insights could pave the way to new approaches for treating bacterial infections that help thwart the emergence of resistance.

Bacteria can acquire resistance to antibiotics through genetic mutations. But they can also defend themselves via collective behaviors such as joining together in a biofilm - a thin, slimy film made up of many bacteria that is less susceptible to antibiotics.

Swarms of bacteria can also undergo a phenomenon similar to human traffic jams called 'motility-induced phase separation', in which they slow down when there are large numbers of bacteria crammed together.

In our study, we wanted to see whether swarming bacteria can use physical interactions such as motility-induced phase separation to overcome certain stresses including exposure to antibiotics."

Iago Grobas, Study First Author and PhD Student, Warwick Medical School, University of Warwick, UK

In their study, Grobas and colleagues exposed a colony of a common environmental bacteria called Bacillus subtilis to an antibiotic called kanamycin in a dish in the laboratory. They recorded a time-lapse video of the bacteria's behavior and found that they formed biofilms in the presence of the drug.

Specifically, the team showed that the biofilm forms because bacteria begin to group together a distance away from the antibiotic, giving way to multiple layers of swarming bacteria.

"The layers build up through a physical mechanism whereby groups of cells moving together collide with each other," Grobas explains. "The collision generates enough stress to pile up the cells, which then move slower, attracting more cells through a mechanism similar to motility-induced phase separation. These multiple layers then lead to biofilm formation."

Next, the team tested a strategy to stop this formation and thereby prevent antibiotic resistance from occurring in this way. They found that splitting a single dose in two steps without changing the total amount of antibiotics strongly reduced the emergence of a biofilm.

The authors say further research is now needed to determine if bacteria that are harmful to humans use similar behaviors to survive antibiotic exposure. If they do, then future treatments should take these behaviors into account in order to reduce antibiotic resistance.

"Our discoveries question the way we use antibiotics and show that increasing the dosage is not always the best way to stop biofilm development," says co-senior author Munehiro Asally, Associate Professor at the School of Life Sciences, University of Warwick. "The timing of the bacteria's exposure to drugs is also important."

"These insights could lead us to rethink the way antibiotics are administered to patients during some infections," concludes co-senior author Marco Polin, Associate Professor at the Department of Physics, University of Warwick, and a researcher at the Mediterranean Institute for Advanced Studies (IMEDEA), Mallorca.

Source:
Journal reference:

Grobas, I., et al. (2021) Swarming bacteria undergo localized dynamic phase transition to form stress-induced biofilms. eLife. doi.org/10.7554/eLife.62632.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections